Drug Type Mesenchymal stem cell therapy |
Synonyms NEPHSTROM ORBCELM, REDDSTAR ORBCELM |
Target- |
Mechanism Cell replacements |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetic Nephropathies | Phase 2 | IT | 05 Dec 2017 | |
Diabetic Foot | Phase 1 | DK | - |